Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-25 @ 4:13 AM
Last Modification Date: 2025-12-25 @ 4:13 AM
Retention: SAMPLES_WITH_DNA
Description: The 1st samples are collected from participants of Breast cancer, phase II-III, HER2+ /or Triple Negative breast cancer will be processed and analyzed to determine detection rate of ctDNA in the blood samples before neoadjuvant chemotherapy.

The 2nd and 3rd samples are collected from participants will be processed and analyzed to determine the change of ctDNA in the blood samples during and after neoadjuvant chemotherapy.
Section: The 1st samples are collected from participants of Breast cancer, phase II-III, HER2+ /or Triple Negative breast cancer will be processed and analyzed to determine detection rate of ctDNA in the blood samples before neoadjuvant chemotherapy. The 2nd and 3rd samples are collected from participants will be processed and analyzed to determine the change of ctDNA in the blood samples during and after neoadjuvant chemotherapy.